Jamy D Ard1, Barbara Gower2, Gary Hunter2,3, Christine S Ritchie4, David L Roth5, Amy Goss2, Brooks C Wingo6, Eric V Bodner7, Cynthia J Brown7, David Bryan2,3, David R Buys8, Marilyn C Haas7, Akilah Dulin Keita9, Lee Anne Flagg10, Courtney P Williams7, Julie L Locher7. 1. Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina. 2. Department of Nutrition Sciences, University of Alabama at Birmingham. 3. Department of Human Studies, University of Alabama at Birmingham. 4. Division of Geriatrics, Department of Medicine, University of California, San Francisco. 5. Division of Geriatric Medicine and Gerontology, Johns Hopkins University, Baltimore, Maryland. 6. Department of Occupational Therapy, University of Alabama at Birmingham. 7. Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham. 8. Department of Food Science, Nutrition, and Health Promotion, Mississippi State University, Starkville. 9. Institute for Community Health Promotion, Brown University, Providence, Rhode Island. 10. Department of Sociology, University of Alabama at Birmingham.
Abstract
BACKGROUND: We lack a comprehensive assessment of the risks and benefits of calorie restriction in older adults at high risk for cardiometabolic disease. Calorie restriction may reduce visceral adipose tissue (VAT) but also have negative effects on lean mass and quality of life. METHODS: We conducted a 52-week, randomized controlled trial involving 164 older adults with obesity taking at least one medication for hyperlipidemia, hypertension, or diabetes. Interventions included an exercise intervention alone (Exercise), or with diet modification and body weight maintenance (Maintenance), or with diet modification and energy restriction (Weight Loss). The primary outcome was change in VAT at 12 months. Secondary outcomes included cardiometabolic risk factors, functional status, and quality of life. RESULTS: A total of 148 participants had measured weight at 12 months. Despite loss of -1.6% ± 0.3% body fat and 4.1% ± 0.7% initial body weight, Weight Loss did not have statistically greater loss of VAT (-192.6 ± 185.2 cm3) or lean mass (-0.4 ± 0.3 kg) compared with Exercise (VAT = -21.9 ± 173.7 cm3; lean mass = 0.3 ± 0.3 kg). Quality of life improved in all groups with no differences between groups. No significant changes in physical function were observed. Weight Loss had significantly greater improvements in blood glucose (-8.3 ± 3.6 mg/dL, p < .05) and HDL-cholesterol (5.3 ± 1.9, p < .01) compared with Exercise. There were no group differences in the frequency of adverse events. CONCLUSIONS: While moderate calorie restriction did not significantly decrease VAT in older adults at high risk for cardiometabolic disease, it did reduce total body fat and cardiometabolic risk factors without significantly more adverse events and lean mass loss.
BACKGROUND: We lack a comprehensive assessment of the risks and benefits of calorie restriction in older adults at high risk for cardiometabolic disease. Calorie restriction may reduce visceral adipose tissue (VAT) but also have negative effects on lean mass and quality of life. METHODS: We conducted a 52-week, randomized controlled trial involving 164 older adults with obesity taking at least one medication for hyperlipidemia, hypertension, or diabetes. Interventions included an exercise intervention alone (Exercise), or with diet modification and body weight maintenance (Maintenance), or with diet modification and energy restriction (Weight Loss). The primary outcome was change in VAT at 12 months. Secondary outcomes included cardiometabolic risk factors, functional status, and quality of life. RESULTS: A total of 148 participants had measured weight at 12 months. Despite loss of -1.6% ± 0.3% body fat and 4.1% ± 0.7% initial body weight, Weight Loss did not have statistically greater loss of VAT (-192.6 ± 185.2 cm3) or lean mass (-0.4 ± 0.3 kg) compared with Exercise (VAT = -21.9 ± 173.7 cm3; lean mass = 0.3 ± 0.3 kg). Quality of life improved in all groups with no differences between groups. No significant changes in physical function were observed. Weight Loss had significantly greater improvements in blood glucose (-8.3 ± 3.6 mg/dL, p < .05) and HDL-cholesterol (5.3 ± 1.9, p < .01) compared with Exercise. There were no group differences in the frequency of adverse events. CONCLUSIONS: While moderate calorie restriction did not significantly decrease VAT in older adults at high risk for cardiometabolic disease, it did reduce total body fat and cardiometabolic risk factors without significantly more adverse events and lean mass loss.
Authors: Hussein N Yassine; Christine M Marchetti; Raj K Krishnan; Thomas R Vrobel; Frank Gonzalez; John P Kirwan Journal: J Gerontol A Biol Sci Med Sci Date: 2009-01-20 Impact factor: 6.053
Authors: Michael D Jensen; Donna H Ryan; Caroline M Apovian; Jamy D Ard; Anthony G Comuzzie; Karen A Donato; Frank B Hu; Van S Hubbard; John M Jakicic; Robert F Kushner; Catherine M Loria; Barbara E Millen; Cathy A Nonas; F Xavier Pi-Sunyer; June Stevens; Victor J Stevens; Thomas A Wadden; Bruce M Wolfe; Susan Z Yanovski; Harmon S Jordan; Karima A Kendall; Linda J Lux; Roycelynn Mentor-Marcel; Laura C Morgan; Michael G Trisolini; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli Journal: Circulation Date: 2013-11-12 Impact factor: 29.690
Authors: Stephen P Messier; Richard F Loeser; Gary D Miller; Timothy M Morgan; W Jack Rejeski; Mary Ann Sevick; Walter H Ettinger; Marco Pahor; Jeff D Williamson Journal: Arthritis Rheum Date: 2004-05
Authors: M Bouchonville; R Armamento-Villareal; K Shah; N Napoli; D R Sinacore; C Qualls; D T Villareal Journal: Int J Obes (Lond) Date: 2013-07-04 Impact factor: 5.095
Authors: John A Batsis; Alexandra B Zagaria; Emma Brooks; Matthew M Clark; Sean Phelan; Francisco Lopez-Jimenez; Stephen J Bartels; Sivan Rotenberg; Elizabeth Carpenter-Song Journal: J Appl Gerontol Date: 2020-02-15
Authors: John A Batsis; Curtis L Petersen; Matthew M Clark; Summer B Cook; Francisco Lopez-Jimenez; Rima I Al-Nimr; Dawna Pidgeon; David Kotz; Todd A Mackenzie; Stephen J Bartels Journal: J Gerontol A Biol Sci Med Sci Date: 2021-01-01 Impact factor: 6.053
Authors: John A Batsis; Curtis L Petersen; Summer B Cook; Rima I Al-Nimr; Dawna Pidgeon; Todd A Mackenzie; Stephen J Bartels Journal: J Nutr Gerontol Geriatr Date: 2020-09-09
Authors: Anna E Bragg; Kristi M Crowe-White; Amy C Ellis; Matthew Studer; Frank Phillips; Steven Samsel; Jason Parton; Julie L Locher; Jamy D Ard Journal: J Acad Nutr Diet Date: 2021-09-01 Impact factor: 4.910
Authors: Elizabeth M Venditti; Marsha D Marcus; Rachel G Miller; Vincent C Arena; Susan L Greenspan; Bonny Rockette-Wagner Journal: J Gerontol A Biol Sci Med Sci Date: 2021-01-18 Impact factor: 6.053